SoPros
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
SoPros - overview
Established
2018
Location
Tsukuba-shi, Ibaraki, Japan
Primary Industry
Biotechnology
About
SoPros Inc. is a company focused on developing and commercializing innovative microalgae products, emphasizing natural and sustainable solutions for health and wellness in nutritional and cosmetic applications. Founded in 2018 in Tsukuba, Japan, SoPros Inc. specializes in microalgae-based products, having completed one deal as of May 25, 2018.
Details regarding specific pivots or previous company strategies are not noted. SoPros specializes in the development and commercialization of microalgae products, leveraging the unique qualities of microalgae sourced from the Yambaru region of Okinawa, Japan. Their core offerings include a range of nutritional supplements and cosmetic ingredients derived from microalgae, which are designed to enhance health and wellness. The primary end-use cases these products address are in the nutrition and personal care sectors, catering to consumers seeking natural and sustainable health solutions.
The company’s client base includes health food retailers, cosmetic manufacturers, and wellness brands, indicating a strong focus on B2B partnerships. Geographically, SoPros markets its products both domestically within Japan and internationally, targeting health-conscious consumers and businesses looking for innovative, eco-friendly ingredients. SoPros generates revenue through a structured transaction model that primarily includes B2B partnerships with retailers and wholesalers. The firm engages in direct sales of its microalgae-based products to distributors in the health food and cosmetic industries, facilitating a streamlined supply chain to reach end consumers.
Specific pricing plans are established for their flagship 254, which may vary based on order volumes and distribution agreements. By focusing on long-term partnerships with clients, the company aims to foster loyalty and recurring sales, enhancing its market presence in both the domestic and international realms. SoPros plans to expand its product line by launching new microalgae-based nutritional supplements and cosmetic ingredients, with targeted release dates set for late 2023. The company aims to enter new markets, specifically targeting the North American and European health and wellness sectors by the end of 2024.
The recent funding round in May 2018, from Universal Materials Incubator, will support these expansion initiatives by facilitating product development and market entry strategies.
Current Investors
Universal Materials Incubator
Primary Industry
Biotechnology
Sub Industries
Health Foods & Nutritional Supplements, Biotechnology
Website
www.sopros.co.jp
Verticals
Research (Non-Medical)
Company Stage
Early Stage
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.